• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗蠕虫治疗停药后进展性泡型包虫病。

Progressive alveolar echinococcosis after discontinuation of anthelmintic therapy.

出版信息

Parasit Vectors. 2013 Oct 1;6(1):287. doi: 10.1186/1756-3305-6-287.

DOI:10.1186/1756-3305-6-287
PMID:24289745
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3849844/
Abstract

We report a case of a female patient with alveolar echinococcosis (AE) who presented with progressive pulmonary and hepatic lesions and had a fatal outcome. AE affecting the liver, the lungs and the brain had been diagnosed 20 years ago and treated successfully with albendazole and stereotactic gamma knife therapy. Due to severe hair loss albendazole was stopped 14 years before presentation. Lesions had remained stable in imaging studies for at least 11 years, but then had started to progress. Lifelong anthelmintic maintenance therapy and regular follow-up may therefore be crucial in order to prevent such a dramatic clinical course.

摘要

我们报告了一例女性泡型包虫病(AE)患者,其肺部和肝脏病变逐渐加重,最终导致死亡。20 年前,该患者曾被诊断为同时患有肝、肺和脑泡型包虫病,并接受了阿苯达唑和立体定向伽玛刀治疗,治疗效果良好。但在 14 年前,由于严重的脱发,该患者停止了阿苯达唑治疗。在过去的 11 年中,影像学检查显示病变一直稳定,但随后开始进展。因此,终身驱虫维持治疗和定期随访可能对于预防这种戏剧性的临床病程至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe23/3849844/fd2ece04ec74/1756-3305-6-287-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe23/3849844/fd2ece04ec74/1756-3305-6-287-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe23/3849844/fd2ece04ec74/1756-3305-6-287-1.jpg

相似文献

1
Progressive alveolar echinococcosis after discontinuation of anthelmintic therapy.抗蠕虫治疗停药后进展性泡型包虫病。
Parasit Vectors. 2013 Oct 1;6(1):287. doi: 10.1186/1756-3305-6-287.
2
A Case of Human Hepatic Alveolar Echinococcosis Accompanied by Lung and Brain Metastases.肝泡型包虫病伴肺及脑转移 1 例
Korean J Parasitol. 2021 Jun;59(3):291-296. doi: 10.3347/kjp.2021.59.3.291. Epub 2021 Jun 21.
3
A mass in the liver.肝脏中的一个肿块。
J Infect. 2002 Aug;45(2):121-2. doi: 10.1053/jinf.2002.0997.
4
An Imported Case of Disseminated Echinococcosis in Korea.韩国一例播散性棘球蚴病输入病例。
Korean J Parasitol. 2019 Aug;57(4):429-434. doi: 10.3347/kjp.2019.57.4.429. Epub 2019 Aug 31.
5
[Chemotherapy alone or as adjuvant treatment to surgery for alveolar and cystic echinococcosis].[单纯化疗或作为肺泡型和囊型棘球蚴病手术的辅助治疗]
Chirurg. 2000 Jan;71(1):9-15. doi: 10.1007/s001040050002.
6
Fatal alveolar echinococcosis of the lumbar spine.腰椎致命性肺包虫病。
J Clin Microbiol. 2013 Feb;51(2):688-91. doi: 10.1128/JCM.01906-12. Epub 2012 Nov 21.
7
[Continuous therapy with albendazole for hepatic alveolar echinococcosis associated with obstructive jaundice].
Zhonghua Nei Ke Za Zhi. 1996 Apr;35(4):261-4.
8
Alveolar echinococcosis in a Thai patient after migration to an endemic area in Central Europe.一名泰国患者移居中欧流行地区后发生肺泡型棘球蚴病。
Travel Med Infect Dis. 2006 Jan;4(1):34-7. doi: 10.1016/j.tmaid.2004.07.010. Epub 2005 Jul 22.
9
Primary disease recurrence after liver transplantation for alveolar echinococcosis: long-term evaluation in 15 patients.肺泡型肝包虫病肝移植术后原发性疾病复发:15例患者的长期评估
Hepatology. 1999 Oct;30(4):857-64. doi: 10.1002/hep.510300426.
10
Albendazole increases the inflammatory response and the amount of Em2-positive small particles of Echinococcus multilocularis (spems) in human hepatic alveolar echinococcosis lesions.阿苯达唑可增强人类肝泡型包虫病病变中多房棘球绦虫(spems)的炎症反应及Em2阳性小颗粒数量。
PLoS Negl Trop Dis. 2017 May 25;11(5):e0005636. doi: 10.1371/journal.pntd.0005636. eCollection 2017 May.

引用本文的文献

1
Risk factor analysis and prediction of multi-organ metastasis in hepatic alveolar echinococcosis.肝泡型包虫病多器官转移的危险因素分析与预测
Saudi J Gastroenterol. 2025 Mar 1;31(2):75-81. doi: 10.4103/sjg.sjg_240_24. Epub 2025 Jan 31.
2
Advances in the pharmacological treatment of hepatic alveolar echinococcosis: From laboratory to clinic.肝泡型包虫病药物治疗的进展:从实验室到临床
Front Microbiol. 2022 Aug 8;13:953846. doi: 10.3389/fmicb.2022.953846. eCollection 2022.
3
Immunotherapy of alveolar echinococcosis via PD-1/PD-L1 immune checkpoint blockade in mice.

本文引用的文献

1
A systematic review of the epidemiology of echinococcosis in domestic and wild animals.包虫病在家养和野生动物中的流行病学的系统评价。
PLoS Negl Trop Dis. 2013 Jun 6;7(6):e2249. doi: 10.1371/journal.pntd.0002249. Print 2013.
2
Unexpected increase of alveolar echincoccosis, Austria, 2011.2011 年奥地利出现棘球蚴病(包虫病)病例意外增多。
Emerg Infect Dis. 2013 Mar;19(3):475-7. doi: 10.3201/eid1903.120595.
3
Mongolian and Japanese Joint Conference on "Echinococcosis: diagnosis, treatment and prevention in Mongolia" June 4, 2009.
通过PD-1/PD-L1免疫检查点阻断对小鼠肺泡型棘球蚴病进行免疫治疗
Parasite Immunol. 2018 Dec;40(12):e12596. doi: 10.1111/pim.12596. Epub 2018 Nov 4.
4
Progress in the pharmacological treatment of human cystic and alveolar echinococcosis: Compounds and therapeutic targets.人包虫病(囊型和泡型)的药物治疗进展:化合物和治疗靶点。
PLoS Negl Trop Dis. 2018 Apr 20;12(4):e0006422. doi: 10.1371/journal.pntd.0006422. eCollection 2018 Apr.
5
Non-surgical and non-chemical attempts to treat echinococcosis: do they work?治疗棘球蚴病的非手术和非化学方法:它们有效吗?
Parasite. 2014;21:75. doi: 10.1051/parasite/2014071. Epub 2014 Dec 23.
2009 年 6 月 4 日,蒙古和日本联合召开“包虫病:蒙古的诊断、治疗和预防”会议。
Parasit Vectors. 2010 Feb 8;3(1):8. doi: 10.1186/1756-3305-3-8.
4
Expert consensus for the diagnosis and treatment of cystic and alveolar echinococcosis in humans.《包虫病(棘球蚴病、包虫病)临床诊断与治疗专家共识(2023 版)》
Acta Trop. 2010 Apr;114(1):1-16. doi: 10.1016/j.actatropica.2009.11.001. Epub 2009 Nov 30.
5
Alveolar echinococcosis: from a deadly disease to a well-controlled infection. Relative survival and economic analysis in Switzerland over the last 35 years.肺泡型棘球蚴病:从一种致命疾病到一种得到良好控制的感染。瑞士过去35年的相对生存率和经济分析。
J Hepatol. 2008 Jul;49(1):72-7. doi: 10.1016/j.jhep.2008.03.023. Epub 2008 Apr 28.
6
WHO classification of alveolar echinococcosis: principles and application.世界卫生组织肺泡型棘球蚴病分类:原则与应用
Parasitol Int. 2006;55 Suppl:S283-7. doi: 10.1016/j.parint.2005.11.041. Epub 2005 Dec 15.
7
Medical treatment of echinococcosis under the guidance of Good Clinical Practice (GCP/ICH).在《药物临床试验质量管理规范》(GCP/ICH)指导下的棘球蚴病的医学治疗。
Parasitol Int. 2006;55 Suppl:S273-82. doi: 10.1016/j.parint.2005.11.040. Epub 2005 Dec 9.
8
Long-term mebendazole therapy may be parasitocidal in alveolar echinococcosis.长期使用甲苯咪唑治疗可能对肺泡型棘球蚴病有杀寄生虫作用。
J Hepatol. 1998 Dec;29(6):994-8. doi: 10.1016/s0168-8278(98)80129-3.
9
Gamma knife radiosurgery and albendazole for cerebral alveolar hydatid disease.
Clin Infect Dis. 1998 Jun;26(6):1379-82. doi: 10.1086/516351.
10
Guidelines for treatment of cystic and alveolar echinococcosis in humans. WHO Informal Working Group on Echinococcosis.人类囊性和泡状棘球蚴病治疗指南。世界卫生组织棘球蚴病非正式工作组。
Bull World Health Organ. 1996;74(3):231-42.